nwinnovation
High Technology News and Information for the Pacific Northwest Region
Home
Mobile
News and Events
  • Headlines
  • Interviews
  • Events
  • Jobs
  • VC Funds
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
  • People
  • Exits
  • VentureMap
  • PowerSearch
  • FundingSearch
  • Stats
  • Dashboard
  • Satellite
  • Post Jobs
    • About
  • About
  • Contact Us
    		•
    Search News
    Subscribe with Bloglines Subscribe in NewsGator Online Add to My Yahoo
    Monday, April 7, 2008

    Light Sciences Oncology Names Holveck To Board


    Cancer research firm Light Sciences Oncology Inc. revealed Monday that it has appointed David P. Holveck to its board of directors. Holveck, who becomes the boar'’s eighth member, is currently president, chief executive officer and a director of Endo Pharmaceuticals. Prior to Endo, Holveck served as vice president of corporate development and, later, president of Johnson & Johnson Development Corp. He also was president and CEO of Centocor Inc., which Johnson & Johnson acquired in 1999. Before Centecor, Holveck held positions with the General Electric, Corning Glass Works and Abbot Laboratories. Headquartered in Bellevue, Wash., Light Sciences Oncology is developing a novel, light-activated drug treatment for solid tumors.
    posted on Monday, April 7, 2008


    Related companies:
    Light Sciences Oncology

    Related stories:
    > Light Sciences Oncology Raises $40.1M
    > Light Sciences Pulls IPO
    > Light Sciences Oncology Adds $30M In Series B Funding
    > Amnis Raises $11.25M
    > Cell Therapeutics Hires President
    Sign up to receive updates via our daily email newsletter

    Enter your email:


    Previous Issues

     Thursday, November 20, 2008
    Wednesday, November 19, 2008
    Tuesday, November 18, 2008
    Monday, November 17, 2008
    Thursday, November 13, 2008